Edwards Lifesciences Corp. (EW)
90.50
+0.72
(+0.80%)
USD |
NYSE |
Aug 24, 16:00
90.50
0.00 (0.00%)
After-Hours: 20:00
Edwards Lifesciences Gross Profit Margin (Quarterly) : 78.09% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 78.09% |
| March 31, 2026 | 78.16% |
| December 31, 2025 | 78.61% |
| September 30, 2025 | 78.29% |
| June 30, 2025 | 76.81% |
| March 31, 2025 | 77.93% |
| December 31, 2024 | 78.63% |
| September 30, 2024 | 79.33% |
| June 30, 2024 | 78.97% |
| March 31, 2024 | 78.25% |
| December 31, 2023 | 80.18% |
| September 30, 2023 | 78.11% |
| June 30, 2023 | 79.10% |
| March 31, 2023 | 75.38% |
| December 31, 2022 | 78.08% |
| September 30, 2022 | 78.70% |
| June 30, 2022 | 79.21% |
| March 31, 2022 | 77.14% |
| December 31, 2021 | 76.60% |
| September 30, 2021 | 77.03% |
| June 30, 2021 | 76.31% |
| March 31, 2021 | 76.34% |
| December 31, 2020 | 75.25% |
| September 30, 2020 | 74.85% |
| June 30, 2020 | 73.42% |
| Date | Value |
|---|---|
| March 31, 2020 | 75.97% |
| December 31, 2019 | 74.84% |
| September 30, 2019 | 72.10% |
| June 30, 2019 | 70.99% |
| March 31, 2019 | 75.89% |
| December 31, 2018 | 75.84% |
| September 30, 2018 | 75.70% |
| June 30, 2018 | 75.26% |
| March 31, 2018 | 74.06% |
| December 31, 2017 | 73.54% |
| September 30, 2017 | 73.66% |
| June 30, 2017 | 75.18% |
| March 31, 2017 | 75.31% |
| December 31, 2016 | 72.61% |
| September 30, 2016 | 73.21% |
| June 30, 2016 | 72.91% |
| March 31, 2016 | 72.51% |
| December 31, 2015 | 71.15% |
| September 30, 2015 | 72.93% |
| June 30, 2015 | 71.21% |
| March 31, 2015 | 75.18% |
| December 31, 2014 | 73.69% |
| September 30, 2014 | 73.08% |
| June 30, 2014 | 73.19% |
| March 31, 2014 | 71.11% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Stryker Corp. | 66.14% |
| Intuitive Surgical, Inc. | 67.76% |
| Abbott Laboratories | 52.64% |
| Boston Scientific Corp. | 66.50% |
| Zimmer Biomet Holdings, Inc. | 62.91% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 9.37% |
| Return on Assets | 7.23% |
| Return on Invested Capital | 8.78% |
| Profit Margin (Quarterly) | 13.87% |
| Operating Margin (Quarterly) | 30.47% |
| Return on Net Operating Assets | 14.17% |